These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26254317)

  • 1. Preferences for Aftercare Among Persons Seeking Short-Term Opioid Detoxification.
    Stein MD; Anderson BJ; Bailey GL
    J Subst Abuse Treat; 2015 Dec; 59():99-103. PubMed ID: 26254317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overdose history is associated with postdetoxification treatment preference for persons with opioid use disorder.
    Stein MD; Flori JN; Risi MM; Conti MT; Anderson BJ; Bailey GL
    Subst Abus; 2017; 38(4):389-393. PubMed ID: 28692407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification.
    Bailey GL; Herman DS; Stein MD
    J Subst Abuse Treat; 2013 Sep; 45(3):302-5. PubMed ID: 23786852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
    Reif S; Acevedo A; Garnick DW; Fullerton CA
    Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between mortality rates and medication and residential treatment after in-patient medically managed opioid withdrawal: a cohort analysis.
    Walley AY; Lodi S; Li Y; Bernson D; Babakhanlou-Chase H; Land T; Larochelle MR
    Addiction; 2020 Aug; 115(8):1496-1508. PubMed ID: 32096908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification.
    Uebelacker LA; Bailey G; Herman D; Anderson B; Stein M
    J Subst Abuse Treat; 2016 Jul; 66():48-53. PubMed ID: 27211996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aftercare attendance and post-treatment functioning of severely substance dependent residential treatment clients.
    Sannibale C; Hurkett P; van den Bossche E; O'Connor D; Zador D; Capus C; Gregory K; McKenzie M
    Drug Alcohol Rev; 2003 Jun; 22(2):181-90. PubMed ID: 12850905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage to Primary Care for Persons First Receiving Injectable Naltrexone During Inpatient Opioid Detoxification.
    Stein MD; Risi MM; Bailey GL; Anderson BJ
    J Subst Abuse Treat; 2016 May; 64():44-6. PubMed ID: 26920817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Civil commitment experiences among opioid users.
    Christopher PP; Anderson B; Stein MD
    Drug Alcohol Depend; 2018 Dec; 193():137-141. PubMed ID: 30384320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturalistic longitudinal analysis of post-detoxification outcomes in opioid-dependent patients.
    Ivers JH; Zgaga L; Sweeney B; Keenan E; Darker C; Smyth BP; Barry J
    Drug Alcohol Rev; 2018 Apr; 37 Suppl 1():S339-S347. PubMed ID: 28940788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initiating buprenorphine treatment for opioid use disorder during short-term in-patient 'detoxification': a randomized clinical trial.
    Stein M; Herman D; Conti M; Anderson B; Bailey G
    Addiction; 2020 Jan; 115(1):82-94. PubMed ID: 31430414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study.
    David AR; Sian CR; Gebel CM; Linas BP; Samet JH; Sprague Martinez LS; Muroff J; Bernstein JA; Assoumou SA
    J Subst Abuse Treat; 2022 Nov; 142():108870. PubMed ID: 36084559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National trends in substance use treatment admissions for opioid use disorder among adults experiencing homelessness.
    Han BH; Doran KM; Krawczyk N
    J Subst Abuse Treat; 2022 Jan; 132():108504. PubMed ID: 34102461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcome of aftercare participation of alcohol and drug users completing residential treatment.
    Arbour S; Hambley J; Ho V
    Subst Use Misuse; 2011; 46(10):1275-87. PubMed ID: 21615214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heroin refusal self-efficacy and preference for medication-assisted treatment after inpatient detoxification.
    Kenney SR; Bailey GL; Anderson BJ; Stein MD
    Addict Behav; 2017 Oct; 73():124-128. PubMed ID: 28505487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aftercare plans of inpatients undergoing detoxification.
    Tuten M; Jones HE; Lertch EW; Stitzer ML
    Am J Drug Alcohol Abuse; 2007; 33(4):547-55. PubMed ID: 17668340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid overdose and inpatient care for substance use disorder care in Massachusetts.
    Morgan JR; Wang J; Barocas JA; Jaeger JL; Durham NN; Babakhanlou-Chase H; Bharel M; Walley AY; Linas BP
    J Subst Abuse Treat; 2020 May; 112():42-48. PubMed ID: 32199545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of services for mentally ill chemically abusing patients discharged from residential treatment.
    Maynard C; Cox GB; Krupski A; Stark K
    J Behav Health Serv Res; 1999 May; 26(2):219-28. PubMed ID: 10230149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perceived social support and treatment retention on an inpatient addiction treatment unit.
    Westreich L; Heitner C; Cooper M; Galanter M; Guedj P
    Am J Addict; 1997; 6(2):144-9. PubMed ID: 9134076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: Feasibility and initial results.
    Klein AA; Seppala MD
    J Subst Abuse Treat; 2019 Sep; 104():51-63. PubMed ID: 31370985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.